<?xml-stylesheet type="text/xsl" href="ViewNLM-v2.3.xsl"?><!DOCTYPE article PUBLIC "-//NLM//DTD Journal Archiving and Interchange DTD v3.0 20080202//EN" "archivearticle3.dtd"><article xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" article-type="research-article"><?properties open_access?><?DTDIdentifier.IdentifierValue -//NLM//DTD Journal Publishing DTD v2.3 20070202//EN?><?DTDIdentifier.IdentifierType public?><?SourceDTD.DTDName journalpublishing.dtd?><?SourceDTD.Version 2.3?><?ConverterInfo.XSLTName jp2nlmx2.xsl?><?ConverterInfo.Version 2?><front><journal-meta><journal-id journal-id-type="nlm-ta">J Korean Med Sci</journal-id><journal-id journal-id-type="publisher-id">JKMS</journal-id><journal-title-group><journal-title>Journal of Korean Medical Science</journal-title></journal-title-group><issn pub-type="ppub">1011-8934</issn><issn pub-type="epub">1598-6357</issn><publisher><publisher-name>The Korean Academy of Medical Sciences</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="doi">10.3346/jkms.2005.20.3.367</article-id><article-id pub-id-type="pmid">15953854</article-id><article-categories><subj-group subj-group-type="heading"><subject>Original Article</subject></subj-group></article-categories><title-group><article-title>Polymorphisms of High-Affinity IgE Receptor and Histamine-Related Genes in Patients with ASA-Induced Urticaria/Angioedema</article-title></title-group><contrib-group><contrib contrib-type="author"><name><surname>Choi</surname><given-names>Jeong-Hee</given-names></name><xref ref-type="aff" rid="A1"/></contrib><contrib contrib-type="author"><name><surname>Kim</surname><given-names>Seung-Hyun</given-names></name><xref ref-type="aff" rid="A2">*</xref></contrib><contrib contrib-type="author"><name><surname>Suh</surname><given-names>Chang-Hee</given-names></name><xref ref-type="aff" rid="A2">*</xref></contrib><contrib contrib-type="author"><name><surname>Nahm</surname><given-names>Dong-Ho</given-names></name><xref ref-type="aff" rid="A2">*</xref></contrib><contrib contrib-type="author" corresp="yes"><name><surname>Park</surname><given-names>Hae-Sim</given-names></name><xref ref-type="aff" rid="A2">*</xref></contrib></contrib-group><aff id="A1">Department of Pulmonology and Allergy, Bundang Jesaeng General Hospital, Seongnam, Korea.</aff><aff id="A2"><label>*</label>Department of Allergy and Rheumatology, Ajou University School of Medicine, Suwon, Korea.</aff><author-notes><corresp> Address for correspondence: Hae-Sim Park, M.D. Department of Allergy and Rheumatology, Ajou University School of Medicine, San-5, Wonchondong, Yongtong-gu, Suwon 443-721, Korea. Tel: +82.31-219-5196, Fax: +82.31-219-5154, <email>hspark@ajou.ac.kr</email></corresp></author-notes><pub-date pub-type="ppub"><month>6</month><year>2005</year></pub-date><pub-date pub-type="epub"><day>30</day><month>6</month><year>2005</year></pub-date><volume>20</volume><issue>3</issue><fpage>367</fpage><lpage>372</lpage><history><date date-type="received"><day>09</day><month>12</month><year>2004</year></date><date date-type="accepted"><day>19</day><month>1</month><year>2005</year></date></history><permissions><copyright-statement>Copyright &#x000a9; 2005 The Korean Academy of Medical Sciences</copyright-statement><copyright-year>2005</copyright-year><license license-type="open-access" xlink:href="http://creativecommons.org/licenses/by-nc/3.0"><license-p>This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (<ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by-nc/3.0">http://creativecommons.org/licenses/by-nc/3.0</ext-link>) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.</license-p></license></permissions><abstract><p>The pathogenic mechanism of ASA-induced urticaria/angioedema (AIU) is still poorly understood, but it has been known that histamine releasing by cutaneous mast cell activation is considered to be an important role. Considering the importance of histamine in AIU, we speculated that a genetic abnormality of histamine-related genes such as a high-affinity IgE receptor, a metabolic enzyme of histamines and histamine receptors, may be involved in the development of AIU. Enrolled in the study were 110 patients with AIU, 53 patients without ASA hypersensitivity who had various drug allergies presenting as exanthematous skin symptoms, and 99 normal healthy controls (NC). Eleven single nucleotide polymorphisms (SNPs) of the &#x003b2; chain of the high-affinity IgE receptor (FCER1B) and three histamine-related genes-histamine N-methyltransferase (HNMT), histamine H1 receptor (HRH1), histamine H2 receptor (HRH2)-were screened using the SNP-IT assay based on a single base extension method. No significant differences were observed in allele and genotype frequencies, and haplotype frequencies of all the SNPs of FCER1B, HNMT, HRH1, and HRH2 among the three groups (<italic>p</italic>&#x0003e;0.05, respectively). These results suggest that the polymorphisms of FCER1B and the three histamine-related genes may not contribute to the development of AIU phenotype in the Korean population.</p></abstract><kwd-group><kwd>Aspirin</kwd><kwd>Hypersensitivity</kwd><kwd>Urticaria</kwd><kwd>Polymorphism, Genetic</kwd></kwd-group></article-meta></front><body><sec sec-type="intro"><title>INTRODUCTION</title><p>ASA (acetylsalicylic acid, or aspirin) hypersensitivity is usually classified into two clinical types: asthma and urticaria with or without angioedema. Although the two manifestations are combined in some patients, ASA-induced urticaria/angioedema (AIU) may affect a different subpopulation from ASA-intolerant asthma (AIA) (<xref ref-type="bibr" rid="B1">1</xref>). The prevalence of AIU is approximately 0.3% of the normal population (<xref ref-type="bibr" rid="B2">2</xref>) and urticaria symptoms can be aggravated by ASA and other nonsteroidal anti-inflammatory drugs (NSAIDs) in one third of patients with chronic urticaria (<xref ref-type="bibr" rid="B3">3</xref>). It has been reported that urinary methylhistamine is increased in chronic urticaria patients with ASA hypersensitivity after ASA provocation test (<xref ref-type="bibr" rid="B4">4</xref>). The mechanism of ASA hypersensitivity in cutaneous reaction remain largely unknown, but the key cell in urticaria is mast cell, histamine is a key mediator in the urticaria and its clinical symptoms (erythma, angioedema, itching) can be controlled by antihistamines.</p><p>Considering the pathogenic mechanisms of AIU, we can speculate that the polymorphisms of candidate genes involved in histamine release and metabolism and its receptors (H1 and H2 receptors) may be associated with the AIU phenotype. To release histamine from mast cells, the key step is a cross-linking of allergens with IgE, which is bound with the high-affinity IgE receptor (FCER1B) located on their surface (<xref ref-type="bibr" rid="B5">5</xref>). Histamine release via autoantibodies against FCER1B was noted in the pathogenic mechanism of chronic idiopathic urticaria (<xref ref-type="bibr" rid="B6">6</xref>, <xref ref-type="bibr" rid="B7">7</xref>). Several investigators demonstrated a positive association of gene polymorphism of the &#x003b2; chain of FCER1B with high serum total IgE level, atopy or the asthma phenotype (<xref ref-type="bibr" rid="B8">8</xref>-<xref ref-type="bibr" rid="B11">11</xref>). Histamine is metabolized primarily by histamine N-methyltransferase (HNMT) and diamine oxidase (<xref ref-type="bibr" rid="B5">5</xref>). In addition, the effects of histamine are mediated through two types of receptors: the histamine H1 receptor (HRH1) and the histamine H2 receptor (HRH2). HNMT 314C&#x0003e;T, resulting in a T105I amino acid change, has been shown to induce a functional difference in enzyme activity (<xref ref-type="bibr" rid="B12">12</xref>).</p><p>In this study, we analyzed eleven known single nucleotide polymorphisms (SNPs) of the <italic>FCER1B</italic>, <italic>HNMT</italic>, <italic>HRH1</italic>, <italic>HRH2</italic> and their haplotypes in AIU patients, compared with other drug allergy patients presenting as exanthematous skin symptoms, and in normal healthy controls in a Korean population.</p></sec><sec sec-type="methods"><title>MATERIALS AND METHODS</title><sec><title>Subjects</title><p>110 patients with AIU, 53 patients having no ASA hypersensitivity with various drug allergies presenting as skin manifestations (especially maculopapular exanthematus rash), and 99 normal healthy controls were enrolled by the Department of Allergy and Rheumatology, Ajou University Hospital, located in the Republic of Korea. All the subjects were Korean. The phenotype of AIU was defined as those having positive results on an ASA oral provocation test, which was performed with 500 mg of ASA (Rhonal&#x000ae;, KunWha Pharmaceutical Co., Seoul, Korea). Patients having ASA intolerant asthma and AIU were excluded. Normal controls, who had non-atopy, no personal and family history of allergic diseases, and no past history of ASA and other drug hypersensitivity, were recruited from the general population. All subjects gave informed consent, which was then approved by the local ethical committee. Skin prick tests were performed with 12 common aeroallergens (Bencard Co., Bredford, U.K.). Atopy was defined as one or more positive reactions to the skin prick test. Chronic urticaria was defined as the daily or near-daily presence of itchy wheals for more than 6 weeks.</p></sec><sec><title>SNP genotyping for allele frequencies of the candidate genes</title><p>Single nucleotide polymorphism (SNP) genotyping was performed by SNP-IT&#x02122; assays using the SNPstream 25K&#x02122; System (Orchid Biosciences, New Jersey, U.S.A.). Briefly, the genomic DNA region spanning the polymorphic site was amplified using one phosphothiolated primer and one regular PCR primer (<xref ref-type="table" rid="T1">Table 1</xref>). The amplified PCR products were digested with exonucleases. The 5' phosphthiolates protected one strand of the PCR product from exonuclease digestion, resulting in the generation of a single-stranded PCR template. The single-stranded PCR template was overlaid onto a 384 well plate containing a covalently attached SNP-IT&#x02122; primer extension primer designed to hybridize immediately adjacent to the polymorphic site. The SNP-IT&#x02122; primer was extended for a single base with a DNA polymerase and mixture of an appropriate acycloterminator, which was labeled with either FITC or biotin and complementary to the polymorphic nucleotide. The identity of the incorporated nucleotide was determined with serial colorimetric reactions with anti-FITC-AP and streptavidin-HRP, respectively. The results of yellow and/or blue color developments were analyzed with the ELISA reader and the final genotype calls were made with the QCReview&#x02122; program.</p></sec><sec><title>Statistical analysis</title><p>The differences of clinical characteristics between two groups were determined by Student's t-test for continuous variables and chi-square test for categorical variables. The Hardy-Weinberg equilibrium was estimated by chi-square tests. The haplotypes of <italic>FCER1B</italic> and <italic>HNMT</italic> were analyzed with the Haplotyper program based on the Bayesian algorithm (<xref ref-type="bibr" rid="B13">13</xref>), and linkage disequilibrium between loci were measured using Lewontin's &#x02223;D'&#x02223; (<xref ref-type="bibr" rid="B14">14</xref>). Logistic regression models were used for analysis of allele and haplotype frequencies controlling age, sex and atopy as co-variables with alternative models (co-dominant, dominant and recessive models). <italic>P</italic> values were corrected for multiple comparisons with the pairs of groups of interest using the Bonferroni method (<xref ref-type="bibr" rid="B15">15</xref>). A <italic>p</italic> value of 0.05 or less was regarded as significant. All statistical analyses were performed using the software SPSS, version 10.0 (Chicago, IL, U.S.A.).</p></sec></sec><sec sec-type="results"><title>RESULTS</title><sec><title>The clinical characteristics of the study subjects</title><p>The clinical characteristics of the study subjects are summarized in <xref ref-type="table" rid="T2">Table 2</xref>. Significant differences existed in the mean age between the patients with other drug allergies and the other two groups (<italic>p</italic>&#x0003c;0.05, respectively). The prevalence of atopy was 78.6% in AIU patients and 55.5% in patients with other drug allergies, indicating a significant difference (<italic>p</italic>&#x0003c;0.05). Furthermore, significant differences were found in the prevalence of allergic diseases (including bronchial asthma, allergic rhinitis, allergic conjunctivitis, atopic dermatitis and food allergies) between AIU patients (50.9%) and patients with other drug allergies (11.3%, <italic>p</italic>&#x0003c;0.01). Thirty three of AIU patients (33.8%) had chronic urticaria.</p></sec><sec><title>Genotype and allele frequencies of the target genes</title><p>Genotype distributions of all loci were in the Hardy-Weinberg equilibrium (<italic>p</italic>&#x0003e;0.05). Allele and genotype frequencies of each SNP of the four candidate genes are shown in <xref ref-type="table" rid="T3">Table 3</xref>. The frequency of variant allele was extremely low in <italic>FCER1B</italic> I181L (q=0), <italic>HRH1</italic> D349N (q=0) and <italic>HRH2</italic> 826C&#x0003e;T (q=0.003), being excluded from the statistical analysis. No significant differences were found in allele and genotype frequencies among the three groups with alternative models (codominant, dominant and recessive models). When clinical parameters were analyzed according to the genotypes, serum total IgE levels in AIU patients with <italic>FCER1B</italic> G237 allele (n=22, 176.2&#x000b1;239.4 IU/mL) was significantly lower than those with the E237 variant (n=79, 374.1&#x000b1;375.0 IU/mL, <italic>p</italic>=0.004, data not shown). However, no significant differences were observed in atopy rate and serum total IgE level according to the genotypes of the other genes studied (data not shown).</p></sec><sec><title>Haplotype frequencies of the target genes</title><p>There were four haplotypes in <italic>FCER1B</italic> having frequencies of more than 1% among the seven haplotypes observed, and three haplotypes in <italic>HNMT</italic> (<xref ref-type="table" rid="T4">Table 4</xref>). All SNPs in <italic>FCER1B</italic> and <italic>HNMT</italic> showed complete linkage disequilibrium (&#x02223;D'&#x02223;=1 &#x00026; r<sup>2</sup>&#x02260;1), and haplotype 1, 2 and 4 of <italic>FCER1B</italic> are equivalent with <italic>FCER1B</italic>-109T&#x0003e;C, <italic>FCER1B</italic> E237G and <italic>FCER1B</italic><italic>Rsa</italic>I_ex7 (T&#x0003e;C), respectively, and haplotype 1 and 3 of <italic>HNMT</italic> are equivalent with <italic>HNMT</italic> 939A&#x0003e;G and T105I, respectively. No significant differences were found in haplotype frequencies and genotype distributions among the three groups with the alternative model (<xref ref-type="table" rid="T5">Table 5</xref>).</p></sec></sec><sec sec-type="discussion"><title>DISCUSSION</title><p>We investigated 11 SNPs of the four candidate genes (including <italic>FCER1B</italic>, <italic>HNMT</italic>, <italic>HRH1</italic> and <italic>HRH2</italic>) that might be associated with AIU pathogenesis. In the present study, no significant differences were found in allele and genotype frequencies of the SNPs and their haplotypes between the study groups, which suggests that these gene polymorphisms may not be related with the development of AIU phenotype in a Korean population.</p><p>The high affinity IgE receptor is responsible for initiating allergic response. The binding of an allergen to the receptor-bound IgE leads to mast cell activation and the release of histamines, which are responsible for clinical manifestations of urticaria (<xref ref-type="bibr" rid="B16">16</xref>). The receptor is a tetrametric complex composed of an alpha, a beta, and two disulfide-linked gamma chains (<xref ref-type="bibr" rid="B17">17</xref>). While the genes for the alpha and gamma subunits are both located on human and mouse chromosome 1 (<xref ref-type="bibr" rid="B18">18</xref>), the beta gene is located on 11q13 and spans about 10 kb and contains 7 exons (<xref ref-type="bibr" rid="B19">19</xref>). Although polymorphisms of the <italic>FCER1B</italic> gene has been reported to be associated with atopy, total serum IgE level, bronchial hyperresponsiveness, asthma, and the basophilic histamine-releasing activity of asthmatic patients (<xref ref-type="bibr" rid="B8">8</xref>-<xref ref-type="bibr" rid="B11">11</xref>, <xref ref-type="bibr" rid="B20">20</xref>), no previous study has been made of the association between <italic>FCER1B</italic> gene polymorphisms and urticaria/angioedema. This study, therefore, is the first to investigate whether no significant association is found between the <italic>FCER1B</italic> gene polymorphism with the AIU phenotype in a Korean population. Also, autoimmunity against the high affinity IgE receptor has been reported in chronic urticaria and AIU (<xref ref-type="bibr" rid="B6">6</xref>, <xref ref-type="bibr" rid="B7">7</xref>). However, in this study, we could not find any significant associations between the five known SNPs of the <italic>FCER1B</italic> gene and their haplotypes and AIU phenotype. Further studies in a larger cohort will be needed to confirm these negative results in different ethnic populations.</p><p>Histamine is regarded as a leading mediator in acute or chronic urticaria/angioedema and antihistamines are still the main treatment for urticaria/angioedema (<xref ref-type="bibr" rid="B5">5</xref>). Histamine is metabolized primarily by HNMT and diamine oxidase in mammals and the effects of histamine are mediated by three pharmacologically defined receptors termed H1 and H2 (<xref ref-type="bibr" rid="B5">5</xref>, <xref ref-type="bibr" rid="B21">21</xref>). Large individual variations of HNMT activity is found in human tissues. Preuss et al. (<xref ref-type="bibr" rid="B12">12</xref>) have demonstrated that <italic>HNMT</italic> T105I (C&#x0003e;T) is associated with decreased levels of HNMT enzymatic activity; consequently, the presence of the 314T allele would be expected to result in reduced histamine metabolism. Yan et al. (<xref ref-type="bibr" rid="B22">22</xref>) also have shown that the frequency of <italic>HNMT</italic> 314C&#x0003e;T in asthmatics (q=0.18) is significantly higher than in controls (q=0.14, OR=0.9, <italic>p</italic>&#x0003c;0.01) in Caucasians. HRH1 mediates the pro-inflammatory actions in the cytokine release and adhesion process (<xref ref-type="bibr" rid="B23">23</xref>, <xref ref-type="bibr" rid="B24">24</xref>), while HRH2 suppresses the production of the Th1 inducing cytokine IL-12, resulting in a shift of the Th1/Th2 balance toward Th2 dominance (<xref ref-type="bibr" rid="B25">25</xref>). Thus, HRH1 and HRH2 are considered to contribute to the pathogenesis of various allergic diseases. Few studies have been made of these genetic polymorphisms and allergic diseases. Sasaki et al. (<xref ref-type="bibr" rid="B26">26</xref>) have shown that no significant association exists between atopic asthma and polymorphisms of <italic>HRH1</italic>, <italic>HRH2</italic>, and <italic>HNMT</italic> genes in a Japanese population. The same SNPs were screened in this study. Although the frequencies of the SNPs were similar with those of the Japanese study, no significant differences were found among the study groups.</p><p>In conclusion, these results suggest a lack of associations between <italic>FCER1B</italic> (-109T&#x0003e;C, <italic>Rsa</italic>I_in2G&#x0003e;A, I181L, E237G, <italic>Rsa</italic>I_ex7T&#x0003e;C), <italic>HRH1</italic> (-17C&#x0003e;T, D349A), HRH2 (543G&#x0003e;A, 826C&#x0003e;T), and <italic>HNMT</italic> (T105I, 939A&#x0003e;G) gene polymorphisms and their haplotypes and the AIU phenotype in a Korean population.</p></sec></body><back><fn-group><fn fn-type="supported-by"><p>The study was supported by a grant of the Korea Health 21 R &#x00026; D Project, <funding-source>Ministry of Health &#x00026; Welfare, Republic of Korea</funding-source> (<award-id>03-PJ10-PG13-GD01-0002</award-id>).</p></fn></fn-group><ref-list><ref id="B1"><label>1</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Szczeklik</surname><given-names>A</given-names></name><name><surname>Gryglewski</surname><given-names>RJ</given-names></name><name><surname>Czerniawska-Mysik</surname><given-names>G</given-names></name></person-group><article-title>Clinical patterns of hypersensitivity to nonsteroidal anti-inflammatory drugs and their pathogenesis</article-title><source>J Allergy Clin Immunol</source><year>1977</year><volume>60</volume><fpage>276</fpage><lpage>284</lpage><pub-id pub-id-type="pmid">410857</pub-id></element-citation></ref><ref id="B2"><label>2</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Settipane</surname><given-names>RA</given-names></name><name><surname>Constantine</surname><given-names>HP</given-names></name><name><surname>Settipane</surname><given-names>GA</given-names></name></person-group><article-title>Aspirin intolerance and recurrent urticaria in normal adults and children. Epidemiology and review</article-title><source>Allergy</source><year>1980</year><volume>35</volume><fpage>149</fpage><lpage>154</lpage><pub-id pub-id-type="pmid">7386800</pub-id></element-citation></ref><ref id="B3"><label>3</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Grattan</surname><given-names>CE</given-names></name></person-group><article-title>Aspirin sensitivity and urticaria</article-title><source>Clin Exp Dermatol</source><year>2003</year><volume>28</volume><fpage>123</fpage><lpage>127</lpage><pub-id pub-id-type="pmid">12653694</pub-id></element-citation></ref><ref id="B4"><label>4</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Di Lorenzo</surname><given-names>G</given-names></name><name><surname>Pacor</surname><given-names>ML</given-names></name><name><surname>Vignola</surname><given-names>AM</given-names></name><name><surname>Profita</surname><given-names>M</given-names></name><name><surname>Esposito-Pellitteri</surname><given-names>M</given-names></name><name><surname>Biasi</surname><given-names>D</given-names></name><name><surname>Corrocher</surname><given-names>R</given-names></name><name><surname>Caruso</surname><given-names>C</given-names></name></person-group><article-title>Urinary metabolites of histamine and leukotrienes before and after placebo-controlled challenge with ASA and food additives in chronic urticaria patients</article-title><source>Allergy</source><year>2002</year><volume>57</volume><fpage>1180</fpage><lpage>1186</lpage><pub-id pub-id-type="pmid">12464047</pub-id></element-citation></ref><ref id="B5"><label>5</label><element-citation publication-type="book"><person-group person-group-type="author"><name><surname>Church</surname><given-names>MK</given-names></name><name><surname>Shute</surname><given-names>JK</given-names></name><name><surname>Sampson</surname><given-names>AP</given-names></name></person-group><person-group person-group-type="editor"><name><surname>Adkinson</surname><given-names>NF</given-names><suffix>Jr</suffix></name><name><surname>Yunginger</surname><given-names>JW</given-names></name><name><surname>Busse</surname><given-names>WW</given-names></name><name><surname>Bochner</surname><given-names>BS</given-names></name><name><surname>Holgate</surname><given-names>ST</given-names></name><name><surname>Simons</surname><given-names>FER</given-names></name></person-group><article-title>Mast cell-derived mediators</article-title><source>Middleton's allergy principles &#x00026; practice</source><year>2003</year><publisher-loc>Philadelphia</publisher-loc><publisher-name>Mosby, Inc.</publisher-name><fpage>189</fpage><lpage>192</lpage></element-citation></ref><ref id="B6"><label>6</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Asero</surname><given-names>R</given-names></name><name><surname>Lorini</surname><given-names>M</given-names></name><name><surname>Chong</surname><given-names>SU</given-names></name><name><surname>Zuberbier</surname><given-names>T</given-names></name><name><surname>Tedeschi</surname><given-names>A</given-names></name></person-group><article-title>Assessment of histamine-releasing activity of sera from patients with chronic urticaria showing positive autologous skin test on human basophils and mast cells</article-title><source>Clin Exp Allergy</source><year>2004</year><volume>34</volume><fpage>1111</fpage><lpage>1114</lpage><pub-id pub-id-type="pmid">15248858</pub-id></element-citation></ref><ref id="B7"><label>7</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lee</surname><given-names>H</given-names></name><name><surname>Lee</surname><given-names>SH</given-names></name><name><surname>Ro</surname><given-names>JY</given-names></name><name><surname>Lee</surname><given-names>KH</given-names></name></person-group><article-title>Autoantibody against high affinity IgE receptor in chronic idiopathic urticaria</article-title><source>Korean J Dermatol</source><year>2001</year><volume>39</volume><fpage>43</fpage><lpage>49</lpage></element-citation></ref><ref id="B8"><label>8</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hill</surname><given-names>MR</given-names></name><name><surname>Cookson</surname><given-names>WO</given-names></name></person-group><article-title>A new variant of the &#x003b2; subunit of the high-affinity receptor for immunoglobulin E (Fc &#x0025b;RI-&#x003b2; E237G): associations with measures of atopy and bronchial hyperresponsiveness</article-title><source>Hum Mol Genet</source><year>1996</year><volume>5</volume><fpage>959</fpage><lpage>962</lpage><pub-id pub-id-type="pmid">8817330</pub-id></element-citation></ref><ref id="B9"><label>9</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hizawa</surname><given-names>N</given-names></name><name><surname>Yamaguchi</surname><given-names>E</given-names></name><name><surname>Jinushi</surname><given-names>E</given-names></name><name><surname>Kawakami</surname><given-names>Y</given-names></name></person-group><article-title>A common FCER1B gene promoter polymorphism influences total serum IgE levels in a Japanese population</article-title><source>Am J Respir Crit Care Med</source><year>2003</year><volume>161</volume><fpage>906</fpage><lpage>909</lpage><pub-id pub-id-type="pmid">10712341</pub-id></element-citation></ref><ref id="B10"><label>10</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Palmer</surname><given-names>LJ</given-names></name><name><surname>Par&#x000e9;</surname><given-names>PD</given-names></name><name><surname>Faux</surname><given-names>JA</given-names></name><name><surname>Moffatt</surname><given-names>MF</given-names></name><name><surname>Daniels</surname><given-names>SE</given-names></name><name><surname>LeSou&#x000eb;f</surname><given-names>PN</given-names></name><name><surname>Bremner</surname><given-names>PR</given-names></name><name><surname>Mockford</surname><given-names>E</given-names></name><name><surname>Gracey</surname><given-names>M</given-names></name><name><surname>Spargo</surname><given-names>R</given-names></name><name><surname>Musk</surname><given-names>AW</given-names></name><name><surname>Cookson</surname><given-names>WO</given-names></name></person-group><article-title>Fc &#x0025b;RI-&#x003b2; polymorphism and total serum IgE levels in endemically parasitized Australian aborigines</article-title><source>Am J Hum Genet</source><year>1997</year><volume>61</volume><fpage>182</fpage><lpage>188</lpage><pub-id pub-id-type="pmid">9245999</pub-id></element-citation></ref><ref id="B11"><label>11</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Shirakawa</surname><given-names>T</given-names></name><name><surname>Li</surname><given-names>A</given-names></name><name><surname>Dubowitz</surname><given-names>M</given-names></name><name><surname>Dekker</surname><given-names>JW</given-names></name><name><surname>Shaw</surname><given-names>AE</given-names></name><name><surname>Faux</surname><given-names>JA</given-names></name><name><surname>Ra</surname><given-names>C</given-names></name><name><surname>Cookson</surname><given-names>WO</given-names></name><name><surname>Hopkins</surname><given-names>JM</given-names></name></person-group><article-title>Association between atopy and variants of the &#x003b2; subunit of the high-affinity immunoglobulin E receptor</article-title><source>Nat Genetics</source><year>1994</year><volume>7</volume><fpage>125</fpage><lpage>129</lpage><pub-id pub-id-type="pmid">7920628</pub-id></element-citation></ref><ref id="B12"><label>12</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Preuss</surname><given-names>CV</given-names></name><name><surname>Wood</surname><given-names>TC</given-names></name><name><surname>Szumlanski</surname><given-names>CL</given-names></name><name><surname>Raftogianis</surname><given-names>RB</given-names></name><name><surname>Otterness</surname><given-names>DM</given-names></name><name><surname>Girard</surname><given-names>B</given-names></name><name><surname>Scott</surname><given-names>MC</given-names></name><name><surname>Weinshilboum</surname><given-names>RM</given-names></name></person-group><article-title>Human histamine N-methyltransferase pharmacogenetics: common genetic polymorphisms that alter activity</article-title><source>Mol Pharmacol</source><year>1998</year><volume>53</volume><fpage>708</fpage><lpage>717</lpage><pub-id pub-id-type="pmid">9547362</pub-id></element-citation></ref><ref id="B13"><label>13</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Niu</surname><given-names>T</given-names></name><name><surname>Qin</surname><given-names>ZS</given-names></name><name><surname>Xu</surname><given-names>X</given-names></name><name><surname>Liu</surname><given-names>JS</given-names></name></person-group><article-title>Bayesian haplotype inference for mutiple linked single-nucleotide polymorphisms</article-title><source>Am J Hum Genet</source><year>2002</year><volume>70</volume><fpage>157</fpage><lpage>169</lpage><pub-id pub-id-type="pmid">11741196</pub-id></element-citation></ref><ref id="B14"><label>14</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hedrick</surname><given-names>PW</given-names></name></person-group><article-title>Gametic disequilibrium measures: proceed with caution</article-title><source>Genetics</source><year>1987</year><volume>117</volume><fpage>331</fpage><lpage>341</lpage><pub-id pub-id-type="pmid">3666445</pub-id></element-citation></ref><ref id="B15"><label>15</label><element-citation publication-type="book"><person-group person-group-type="author"><name><surname>Altman</surname><given-names>DG</given-names></name></person-group><source>Practical statistics for medical research</source><year>1997</year><publisher-loc>London</publisher-loc><publisher-name>Chapman &#x00026; Hall</publisher-name></element-citation></ref><ref id="B16"><label>16</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Dombrowicz</surname><given-names>D</given-names></name><name><surname>Flamand</surname><given-names>V</given-names></name><name><surname>Brigman</surname><given-names>KK</given-names></name><name><surname>Koller</surname><given-names>BH</given-names></name><name><surname>Kinet</surname><given-names>JP</given-names></name></person-group><article-title>Abolition of anaphylaxis by targeted disruption of the high affinity immunoglobulin E recptor &#x003b1; chain gene</article-title><source>Cell</source><year>1993</year><volume>75</volume><fpage>969</fpage><lpage>976</lpage><pub-id pub-id-type="pmid">8252632</pub-id></element-citation></ref><ref id="B17"><label>17</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Blank</surname><given-names>U</given-names></name><name><surname>Ra</surname><given-names>C</given-names></name><name><surname>Miller</surname><given-names>L</given-names></name><name><surname>White</surname><given-names>K</given-names></name><name><surname>Metzger</surname><given-names>H</given-names></name><name><surname>Kinet</surname><given-names>JP</given-names></name></person-group><article-title>Complete sturucture and expression in transfected cells of high affinity IgE receptor</article-title><source>Nature</source><year>1989</year><volume>337</volume><fpage>187</fpage><lpage>189</lpage><pub-id pub-id-type="pmid">2521376</pub-id></element-citation></ref><ref id="B18"><label>18</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hupp</surname><given-names>K</given-names></name><name><surname>Siwarski</surname><given-names>D</given-names></name><name><surname>Mock</surname><given-names>BA</given-names></name><name><surname>Kinet</surname><given-names>JP</given-names></name></person-group><article-title>Gene mapping of the three subunits of the high affinity FcR for IgE to mouse chromosomes 1 and 19</article-title><source>J Immunol</source><year>1989</year><volume>143</volume><fpage>3787</fpage><lpage>3791</lpage><pub-id pub-id-type="pmid">2531187</pub-id></element-citation></ref><ref id="B19"><label>19</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sandford</surname><given-names>AJ</given-names></name><name><surname>Shirakawa</surname><given-names>T</given-names></name><name><surname>Moffatt</surname><given-names>MF</given-names></name><name><surname>Daniels</surname><given-names>SE</given-names></name><name><surname>Ra</surname><given-names>C</given-names></name><name><surname>Faux</surname><given-names>JA</given-names></name><name><surname>Young</surname><given-names>RP</given-names></name><name><surname>Nakamura</surname><given-names>Y</given-names></name><name><surname>Lathrop</surname><given-names>GM</given-names></name><name><surname>Cookson</surname><given-names>WO</given-names></name><name><surname>Hopkin</surname><given-names>JM</given-names></name></person-group><article-title>Localisation of atopy and beta subunit of high-affinity IgE receptor (FCER1) on chromosome 11q</article-title><source>Lancet</source><year>1993</year><volume>341</volume><fpage>332</fpage><lpage>334</lpage><pub-id pub-id-type="pmid">8094113</pub-id></element-citation></ref><ref id="B20"><label>20</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kim</surname><given-names>YK</given-names></name><name><surname>Oh</surname><given-names>SY</given-names></name><name><surname>Oh</surname><given-names>HB</given-names></name><name><surname>Chun</surname><given-names>SY</given-names></name><name><surname>Cho</surname><given-names>SH</given-names></name><name><surname>Koh</surname><given-names>YY</given-names></name><name><surname>Min</surname><given-names>KU</given-names></name><name><surname>Kim</surname><given-names>YY</given-names></name></person-group><article-title>Coding single nucleotide polymorphism in the high-affinity immunoglobulin E receptor &#x003b2; chain (Fc &#x0025b;RI-&#x003b2;) gene is associated with immunoglobulin E receptor-mediated histamine release from basophils</article-title><source>Clin Exp Allergy</source><year>2002</year><volume>32</volume><fpage>751</fpage><lpage>755</lpage><pub-id pub-id-type="pmid">11994101</pub-id></element-citation></ref><ref id="B21"><label>21</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hill</surname><given-names>SJ</given-names></name><name><surname>Ganellin</surname><given-names>CR</given-names></name><name><surname>Timmerman</surname><given-names>H</given-names></name><name><surname>Schwartz</surname><given-names>JC</given-names></name><name><surname>Shankley</surname><given-names>NP</given-names></name><name><surname>Young</surname><given-names>JM</given-names></name><name><surname>Schunack</surname><given-names>W</given-names></name><name><surname>Levi</surname><given-names>R</given-names></name><name><surname>Haas</surname><given-names>HL</given-names></name></person-group><article-title>International union of pharmacology. XIII. Classification of histamine receptors</article-title><source>Pharmacol Rev</source><year>1997</year><volume>49</volume><fpage>253</fpage><lpage>278</lpage><pub-id pub-id-type="pmid">9311023</pub-id></element-citation></ref><ref id="B22"><label>22</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yan</surname><given-names>L</given-names></name><name><surname>Galinsky</surname><given-names>RE</given-names></name><name><surname>Bernstein</surname><given-names>JA</given-names></name><name><surname>Liggett</surname><given-names>SB</given-names></name><name><surname>Weinshilboum</surname><given-names>RM</given-names></name></person-group><article-title>Histamine N-methyltransferase pharmacogenetics: association of a common functional polymorphism with asthma</article-title><source>Pharmacogenetics</source><year>2000</year><volume>10</volume><fpage>261</fpage><lpage>266</lpage><pub-id pub-id-type="pmid">10803682</pub-id></element-citation></ref><ref id="B23"><label>23</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bachert</surname><given-names>C</given-names></name></person-group><article-title>Histamine-a major role in allergy?</article-title><source>Clin Exp Allergy</source><year>1998</year><volume>28</volume><fpage>15</fpage><lpage>19</lpage><pub-id pub-id-type="pmid">9988429</pub-id></element-citation></ref><ref id="B24"><label>24</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Banu</surname><given-names>Y</given-names></name><name><surname>Watanabe</surname><given-names>T</given-names></name></person-group><article-title>Augmentation of antigen receptor-mediated responses by histamine H1 receptor signaling</article-title><source>J Exp Med</source><year>1999</year><volume>189</volume><fpage>673</fpage><lpage>682</lpage><pub-id pub-id-type="pmid">9989982</pub-id></element-citation></ref><ref id="B25"><label>25</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>van der Pouw Kraan</surname><given-names>TC</given-names></name><name><surname>Snijders</surname><given-names>A</given-names></name><name><surname>Boeije</surname><given-names>LC</given-names></name><name><surname>de Groot</surname><given-names>ER</given-names></name><name><surname>Alewijnse</surname><given-names>AE</given-names></name><name><surname>Leurs</surname><given-names>R</given-names></name><name><surname>Aarden</surname><given-names>LA</given-names></name></person-group><article-title>Histamine inhibits the production of interleukin-12 through interaction with H2 receptors</article-title><source>J Clin Invest</source><year>1998</year><volume>102</volume><fpage>1866</fpage><lpage>1873</lpage><pub-id pub-id-type="pmid">9819373</pub-id></element-citation></ref><ref id="B26"><label>26</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sasaki</surname><given-names>Y</given-names></name><name><surname>Ihara</surname><given-names>K</given-names></name><name><surname>Ahmed</surname><given-names>S</given-names></name><name><surname>Yamawaki</surname><given-names>K</given-names></name><name><surname>Kusuhara</surname><given-names>K</given-names></name><name><surname>Nakayama</surname><given-names>H</given-names></name><name><surname>Nishima</surname><given-names>S</given-names></name><name><surname>Hara</surname><given-names>T</given-names></name></person-group><article-title>Lack of association between atopic asthma and polymorphisms of the histamine H1 receptor, histamine H2 receptor, and histamine N-methyl transferase genes</article-title><source>Immunogenetics</source><year>2000</year><volume>51</volume><fpage>238</fpage><lpage>240</lpage><pub-id pub-id-type="pmid">10752634</pub-id></element-citation></ref></ref-list></back><floats-group><table-wrap id="T1" position="float"><label>Table 1</label><caption><p>Amplifying and extension primers of the candidate genes</p></caption><graphic xlink:href="jkms-20-367-i001"/><table-wrap-foot><fn><p>For/Rev, forward/reverse amplifying primers; E, glutamate; G, glycine; I, isoleucine; L, leucine; T, threonine; D, aspartate; N, asparagine.</p></fn></table-wrap-foot></table-wrap><table-wrap id="T2" position="float"><label>Table 2</label><caption><p>Clinical characteristics of the study subjects</p></caption><graphic xlink:href="jkms-20-367-i002"/><table-wrap-foot><fn><p>AIU, ASA-induced urticaria/angioedema; MPE, maculopapular exanthematous rash; NC, normal control; NA, non applicable; NS, non significant</p></fn></table-wrap-foot></table-wrap><table-wrap id="T3" position="float"><label>Table 3</label><caption><p>The allele and genotype frequencies of the SNPs in the candidate genes</p></caption><graphic xlink:href="jkms-20-367-i003"/><table-wrap-foot><fn><p><sup>*</sup>Each <italic>p</italic> value was calculated with co-dominant, dominant and recessive models. Logistic regression analysis was applied to control for age, sex atopy as covariables. E, glutamate; G, glycine; T, threonine; I, isoleucine; AIU, ASA-induced urticaria/angioedema; NS, non significant.</p></fn></table-wrap-foot></table-wrap><table-wrap id="T4" position="float"><label>Table 4</label><caption><p>Haplotype frequencies of <italic>FCER1B</italic> and <italic>HNMT</italic></p></caption><graphic xlink:href="jkms-20-367-i004"/><table-wrap-foot><fn><p><sup>*</sup>Logistic regression analysis was applied to control for age, sex atopy as covariables. Rare alleles are given in bold. AIU, ASA-induced urticaria/angioedema; NA, non applicable.</p></fn></table-wrap-foot></table-wrap><table-wrap id="T5" position="float"><label>Table 5</label><caption><p>Genotype distributions of haplotypes of <italic>FCER1B</italic> and <italic>HNMT</italic></p></caption><graphic xlink:href="jkms-20-367-i005"/><table-wrap-foot><fn><p><sup>*</sup>Each <italic>p</italic> value was calculated with co-dominant, dominant and recessive models. Logistic regression analysis was applied to control for age, sex atopy as covariables. AIU, ASA-induced urticaria/angioedema; NS, non significant.</p></fn></table-wrap-foot></table-wrap></floats-group></article>